Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 1.10% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Patch availableJerryScript version Tested on commit f86d7459d195c8ba58479d1861b0cc726c8b3793. Analysing history it seems that the issue has been present since commit 64a340ffeb8809b2b66bbe32fd443a8b79fdd860 contains a CWE-476: NULL Pointer Dereference vulnerability in Triggering undefined behavior at jerry-core/ecma/builtin-objects/typedarray/ecma-builtin-typedarray-prototype.c:598 (passing NULL to memcpy as 2nd argument) results in null pointer dereference (segfault) at jerry-core/jmem/jmem-heap.c:463 that can result in Crash due to segmentation fault. This attack appear to be exploitable via The victim must execute specially crafted javascript code. This vulnerability appears to have been fixed in after commit 87897849f6879df10e8ad68a41bf8cf507edf710.
JerryScript version Tested on commit f86d7459d195c8ba58479d1861b0cc726c8b3793. Analysing history it seems that the issue has been present since commit 64a340ffeb8809b2b66bbe32fd443a8b79fdd860 contains a CWE-476: NULL Pointer Dereference vulnerability in Triggering undefined behavior at jerry-core/ecma/builtin-objects/typedarray/ecma-builtin-typedarray-prototype.c:598 (passing NULL to memcpy as 2nd argument) results in null pointer dereference (segfault) at jerry-core/jmem/jmem-heap.c:463 that can result in Crash due to segmentation fault. This attack appear to be exploitable via The victim must execute specially crafted javascript code. This vulnerability appears to have been fixed in after commit 87897849f6879df10e8ad68a41bf8cf507edf710.
The product dereferences a pointer that it expects to be valid but is NULL.
An attacker operating through a network path may attempt exploitation without authentication after a user interaction. If successful, the issue may disrupt the affected service.
JerryScript version Tested on commit f86d7459d195c8ba58479d1861b0cc726c8b3793. Analysing history it seems that the issue has been present since commit 64a340ffeb8809b2b66bbe32fd443a8b79fdd860 contains a CWE-476: NULL Pointer Dereference vulnerability in Triggering undefined behavior at jerry-core/ecma/builtin-objects/typedarray/ecma-builtin-typedarray-prototype.c:598 (passing NULL to memcpy as 2nd argument) results in null pointer dereference (segfault) at jerry-core/jmem/jmem-heap.c:463 that can result in Crash due to segmentation fault. This attack appear to be exploitable via The victim must execute specially crafted javascript code. This vulnerability appears to have been fixed in after commit 87897849f6879df10e8ad68a41bf8cf507edf710.
The product dereferences a pointer that it expects to be valid but is NULL.
An attacker operating through a network path may attempt exploitation without authentication after a user interaction. If successful, the issue may disrupt the affected service.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-476: NULL Pointer Dereference. The product dereferences a pointer that it expects to be valid but is NULL.
CVSS:3.0/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:HCommon Vulnerability Scoring System 3.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 20 Aug 2018 · Last source change 17 Sept 2024, 02:41 UTC · CWE-476 · NULL Pointer Dereference
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.